He led the global team that developed and commercialized Xience, a family of drug eluting stents (DES) and market leader for the treatment of coronary artery disease while serving as Vice President and General Manager of Drug Eluting Stents, Vascular Intervention at Guidant based in Santa Clara, California (US).